Brief: Akeso Posts H1 Gross Profit RMB 943.2 Million
28/08/2024 14:58
Aug 28 (Reuters) - Akeso H1 revenue RMB 1,024.7 million. * H1 gross profit RMB 943.2 million
Recent news on Akeso
See all newsBrief: Akeso Announces Summit Therapeutics And Ecog-Acrin Cancer Research Group Enter Into Phase Ii/Iii Clinical Trial Collaboration To Evaluate Ivonescimab In First-Line Biliary Tract Cancer
Factbox: Major drugmakers turn to China for licensing deals
HK-listed Akeso drops most in nearly three months on discounted share sale
Brief: Akeso To Place 20 Million New Shares At HK$97.76 Per Share
Factbox: Major drugmakers turn to China for licensing deals